Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Baxter expects $200M hit from hurricane/flooding

<< Previous

Bullboard Posts

Next >>

Comment by BlueJays9293on Nov 09, 2024 12:09am

111 Views

Post# 36304399

RE:RE:RE:Baxter expects $200M hit from hurricane/flooding

Not to harp on things, but if we don't build into the system, even just a mandatory 4 month reserve bare minimum, of bronchodilators aka asthma pumps, then we are taking extremely unnecssary risk as a society. IV fluid??? C'mon...

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market